This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A Progress Report

Regina Rabinovich, MD; Anthony Robbins, MD

JAMA. 1994;271(1):68-69.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Since pertussis vaccines were introduced in the 1940s, physicians have recognized their association with adverse events, and this association has continued to the present time.

Today we use whole-cell vaccines made up of killed inactivated organisms of Bordatella pertussis that contain a multitude of antigens, some of which induce protection to severe whooping cough. Several of these materials, such as endotoxin, may account for these vaccines' reactogenicity. Commonly reported minor reactions include pain and swelling at the injection site, fever, and vomiting. More worrisome to parents and physicians are episodes of somnolence, febrile seizures, unusual prolonged screaming, and hyporesponsive-hypotonic episodes; yet none of these has been demonstrated to be associated with permanent sequelae.¹ . . . [Full Text PDF of this Article]

Author Affiliations
From the National Vaccine Program, US Public Health Service, US Department of Health and Human Services, Washington, DC.

Footnotes
Reprint requests to the National Vaccine Program, US Public Health Service, US Department of Health and Human Services, Room 730 E, 200 Independence Ave SW, Washington, DC 20201 (Dr Rabinovich).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?